Zobrazeno 1 - 10
of 59
pro vyhledávání: '"David Žižek"'
Autor:
Anja Zupan Mežnar, Jan Alatič, Juš Kšela, Marko Miklič, Matevž Jan, Franjo Husam Naji, Damijan Vokač, David Žižek
Publikováno v:
Zdravniški Vestnik, Vol 92, Iss 5-6, Pp 275-282 (2023)
Cardiac implantable electronic devices (CIEDs) are an established treatment option for arrhythmias, sudden cardiac death prevention, and heart failure. Approximately 1000 devices are implanted per million inhabitants in European countries each year.
Externí odkaz:
https://doaj.org/article/d233ce82814149c1857ea3b57c657027
Autor:
Peter Marko Mihailovič, David Žižek, Luka Vitez, Primoz Holc, Tomislav Klokočovnik, Matjaž Bunc
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
BackgroundAortic regurgitation is a major concern following transcatheter aortic valve implantation (TAVI), as even low-grade regurgitation is associated with increased mortality. This is of particular concern to patients with pre-existing aortic dis
Externí odkaz:
https://doaj.org/article/43d1c6b904b8493a93d04191b1da746c
Autor:
Tine Prolič Kalinšek, David Žižek
Publikováno v:
BMC Cardiovascular Disorders, Vol 22, Iss 1, Pp 1-5 (2022)
Abstract Background Left bundle branch area pacing (LBBAP) is an alternative to right ventricular (RV) and biventricular (BiV) pacing in patients scheduled for pace and ablate treatment strategy. However, current delivery sheaths are designed for lef
Externí odkaz:
https://doaj.org/article/582eff53122d4113820c8d4f9d2daf47
Publikováno v:
Reviews in Cardiovascular Medicine, Vol 24, Iss 12, p 368 (2023)
Background: Treatment with a coronary sinus reducer (CSR) is a new therapeutic option for refractory angina patients. Preclinical studies have shown antiarrhythmic properties of coronary sinus narrowing. The possible antiarrhythmic effect of CSR impl
Externí odkaz:
https://doaj.org/article/812b5705647a42598c25031236ca95cd
Publikováno v:
Reviews in Cardiovascular Medicine, Vol 24, Iss 11, p 333 (2023)
Background: “Ablate and pace” strategy is a reasonable treatment option in refractory atrial fibrillation (AF) when sinus rhythm (SR) cannot be achieved with catheter ablation or pharmacological therapy. Atrioventricular node ablation (AVNA) comb
Externí odkaz:
https://doaj.org/article/477dd81180c143ba841c01a8865181a4
Autor:
Tine Prolič Kalinšek, Jernej Šorli, Matevž Jan, Matjaž Šinkovec, Bor Antolič, Luka Klemen, David Žižek, Andrej Pernat
Publikováno v:
BMC Cardiovascular Disorders, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Purpose The aim of this study was to evaluate the safety and efficacy of zero-fluoroscopy (ZF) catheter ablation (CA) for supraventricular tachycardias (SVT). Methods 584 consecutive patients referred to our institution for CA of SVT were an
Externí odkaz:
https://doaj.org/article/5e35e0c2a09c42e38236a67319c8b10d
Autor:
Mirko Topalović, Matevž Jan, Tine Prolič Kalinšek, David Žižek, Jernej Štublar, Rina Rus, Dimitrij Kuhelj
Publikováno v:
Children, Vol 10, Iss 9, p 1513 (2023)
Catheter ablation (CA) of supraventricular tachycardias (SVTs) is conventionally performed with the aid of X-ray fluoroscopy. Usage of a three-dimensional (3D) electro-anatomical mapping (EAM) system and intracardiac echocardiography (ICE) enables ze
Externí odkaz:
https://doaj.org/article/0b47011386b14d98a08ef2bbe1eff76d
Publikováno v:
Zdravniški Vestnik, Vol 90, Iss 11-12, Pp 587-595 (2021)
Background: High right ventricular (RV) pacing burden may promote left ventricular dysfunction. Recently, His bundle pacing (HBP) has emerged as an alternative method to RV pacing that provides physiological ventricular activation by directly stimula
Externí odkaz:
https://doaj.org/article/d7c48b4309504762b9886d0c043412a3
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 9 (2022)
Tachycardia-induced cardiomyopathy (T-CMP) related to supraventricular arrhythmia is a rare and often unrecognized cause of refractory cardiogenic shock. When rhythm control interventions are ineffective or no longer pursued, atrioventricular node ab
Externí odkaz:
https://doaj.org/article/40be36d151a84e4aa89d82453021378b
Publikováno v:
Zdravniški Vestnik, Vol 90, Iss 7-8, Pp 410-419 (2021)
Zdravljenje atrijske fibrilacije (AF) je hitro razvijajoče se področje kardiologije, pri katerem smo priča stalnemu razvoju različnih oblik tehničnih izboljšav in multidisciplinarnega pristopa. Poleg iskanja najprimernejšega ablacijskega nači
Externí odkaz:
https://doaj.org/article/f504180ccd8e4140807b6e56ba03a04d